ASX:NTI Neurotech International (NTI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Neurotech International Stock (ASX:NTI) 30 days 90 days 365 days Advanced Chart Get NTI alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationA$45.85 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its products includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. Neurotech International Limited was incorporated in 2016 and is based in Nedlands, Australia. Read More Receive NTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neurotech International and its competitors with MarketBeat's FREE daily newsletter. Email Address NTI Stock News HeadlinesNeurotech International Relocates Headquarters to MelbourneJuly 10, 2025 | tipranks.comNeurotech’s cannabinoid drug reports positive results from key studyJune 2, 2025 | msn.comMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.August 5 at 2:00 AM | Brownstone Research (Ad)Aussie researchers and ASX biotechs driving paediatric drug breakthroughsMay 22, 2025 | msn.comNeurotech’s NTI164 shows excellent tolerability in key preclinical toxicology studiesMay 5, 2025 | msn.comNeurotech International Updates Trading Policy to Enhance ComplianceApril 15, 2025 | tipranks.comKRTL Holding Announces Acquisition of Neurogen Brain Balancing, LLC – A Strategic Merger Accelerating Global Neurotech and Mental Wellness ExpansionApril 11, 2025 | markets.businessinsider.comNeurotech International Issues New Shares, Ensures Regulatory ComplianceApril 2, 2025 | tipranks.comSee More Headlines NTI Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Neurotech International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Neurotech International investors own include Standard Chartered (SCBFY), Advocate Rising Rate Hedge ETF (RRH), Defiance Next Gen H2 ETF (HDRO) and Cleveland-Cliffs (CLF). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryPetroleum And Natural Gas Current SymbolASX:NTI CIKN/A Webwww.neurotechinternational.com Phone61 8 9389 3130FaxN/AEmployees7,134Year FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$5.07 million Net Margins15,972.18% Pretax MarginN/A Return on Equity-60.73% Return on Assets-37.29% Debt Debt-to-Equity RatioN/A Current Ratio38.81 Quick Ratio3.36 Sales & Book Value Annual SalesA$3.18 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.01 per share Price / BookN/AMiscellaneous Outstanding Shares1,030,000,000Free FloatN/AMarket CapA$45.85 million OptionableNot Optionable Beta1.46 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (ASX:NTI) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurotech International Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurotech International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
